NCT05043766 - Evaluation of Oral PF614 Relative to OxyContin (PF614-102) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 8, 2021

Primary Completion Date

March 21, 2022

Study Completion Date

March 21, 2022

Conditions

Healthy Volunteers

Interventions

DRUG

PF614

PF614 is an oxycodone prodrug

DRUG

Naltrexone Hydrochloride

Naltrexone HCl tablets, 50 mg, will be used to block the opioid effects in healthy volunteers

DRUG

OxyContin

Bioequivalence single-dose comparison to OxyContin

Trial Locations (1)

PRA Health Sciences-Early Development Services, Salt Lake City